| Ticker | ARQT |
|---|---|
| ISIN | US03969K1088 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus k...
El precio actual de Arcutis Biotherapeutics, Inc. (ARQT) es de 23,26 , con una variación del 1,75%.
Arcutis Biotherapeutics, Inc. opera en el sector Healthcare, industria Biotechnology.